Clinical trials: Tuberculosis, Extra-Pulmonary
Pulmonary Tuberculosis, Extra Pulmonary Tuberculosis
Tuberculosis Cohort in the North of Paris
Tuberculosis (TB) is the leading cause of death from infectious disease in the world, just behind HIV / AIDS. Since 2005, the department of Seine Saint Denis, the poorest of France with difficult socio-economic conditions, has…
- Trial name
- NCT04236349
- Testing
- immunogenetics
- Where
- France
- Volunteers
- 30 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Tuberculosis
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
This study will examine an enhanced protocol to systematically screen a cohort of 400 new HIV clinic enrollees for prevalence and 1-year incidence of tuberculosis (TB).
- Trial name
- NCT02043067
- Testing
- Comprehensive TB screening
- Where
- Zambia
- Volunteers
- 400 people
- Sponsor
- University of North Carolina, Chapel Hill
Extra Pulmonary Tuberculosis
Role of Genexpert in Extra Pulmonary Tuberculosis
Diagnosis of extra pulmonary tuberculosis remains especially challenging since the number of Mycobacterium tuberculosis bacilli present in tissues at sites of disease is often low and clinical specimens from deep-seated organs…
- Trial name
- NCT03173261
- Testing
- Genexpert
- Volunteers
- 2 people
- Sponsor
- Assiut University
Pulmonary and Extra- Pulmonary Tuberculosis (TB)
Study About Drug Resistance of Mycobacterium Tuberculosis
Tuberculosis is a major cause of ill health and one of the leading causes of death worldwide. Early, rapid and accurate diagnosis of all TB patients and prompt treatment with any form of drug-susceptible or drug resistant TB is…
- Trial name
- NCT07169149
- Where
- Egypt
- Volunteers
- 250 people
- Sponsor
- Sohag University